- Friday 1st of October 2021
Is Filitra 20 Effective In Treating ED Related To Obesity?
Filitra 20 is a medication used to manage Erectile Dysfunction, particularly in men who struggle to achieve or maintain a firm erection. It contains the active ingredient Vardenafil, which improves blood flow to the penis during sexual stimulation. This mechanism can make the drug effective even when erectile dysfunction is linked to underlying conditions such as Obesity.
How Obesity Contributes to ED
Obesity is known to increase the risk of erectile dysfunction because it can lead to poor blood circulation, hormonal imbalances, and reduced testosterone levels. Excess body fat is also associated with conditions like Type 2 Diabetes and Hypertension, both of which may damage blood vessels and nerves involved in the erection process.
Effectiveness of Filitra 20
Filitra 20 mg works by relaxing the blood vessels in the penile region and increasing blood flow when a man is sexually aroused. For individuals with obesity-related ED, this improved circulation can help produce firmer and longer-lasting erections. Many men find that the medication begins working within 30 to 60 minutes and provides reliable support for sexual performance.
Additional Considerations
While Filitra 20 can be effective, addressing lifestyle factors such as weight management, regular exercise, and a balanced diet can further improve erectile function and overall health. Consulting a healthcare professional ensures safe use and appropriate treatment for obesity-related ED.
Latest News
- Friday 1st of October 2021
“BIZ 2021” Entrepreneurial Day competition
- Friday 1st of October 2021
Workshop on modern assessment and the Use of Zoom Software in Learner-Centered Classroom (Academic staff)
- Friday 19th of March 2021
“Let’s Plant Trees for a Better Environment 2021”
- Friday 19th of March 2021
Biz 2020 – UWU Entrepreneurs’ Day
- Friday 19th of March 2021
Faculty of Management signs MoU with the Sri Lanka Institute of Marketing
- Friday 19th of March 2021
0 Replies:
Leave a Reply